Thyroid Eye Disease

Thyroid Eye Disease (TED), also referred to as thyroid orbitopathy or Graves’ orbitopathy, is an autoimmune inflammatory condition affecting the tissues around the eyes. Commonly associated with hyperthyroidism, particularly Graves’ disease, TED may also occur in euthyroid or hypothyroid individuals. This disorder can lead to significant ocular discomfort, vision impairment, and disfigurement if left untreated.

Thyroid Carcinoma

Thyroid carcinoma refers to a malignant tumor arising from the epithelial cells of the thyroid gland. As the most common endocrine malignancy, thyroid cancer has shown a rising incidence globally. While most thyroid carcinomas are indolent and highly treatable, certain aggressive subtypes present significant clinical challenges. Early detection, accurate classification, and a multidisciplinary approach are

Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening hematologic condition characterized by widespread formation of small blood clots (thrombi) in arterioles and capillaries throughout the body. This leads to thrombocytopenia, microangiopathic hemolytic anemia, and multiorgan dysfunction, particularly affecting the brain, kidneys, and heart. Prompt diagnosis and treatment are essential to prevent irreversible organ damage and

Thrombosis Prevention in Heparin-Induced Thrombocytopenia

Heparin-induced thrombocytopenia (HIT) is a life-threatening, immune-mediated complication of heparin therapy, characterized by a significant drop in platelet count and an increased risk of thrombosis. Paradoxically, despite thrombocytopenia, patients with HIT are at an exceptionally high risk of both arterial and venous thrombotic events. Prompt diagnosis and intervention are critical to reducing morbidity and mortality.

Thrombosis in Heparin-Induced Thrombocytopenia (HIT)

Heparin-induced thrombocytopenia (HIT) is a prothrombotic, immune-mediated adverse reaction to heparin exposure. Paradoxically, HIT causes thrombosis rather than bleeding, despite the hallmark of thrombocytopenia. It typically occurs 4–14 days after initiation of heparin and can lead to arterial or venous thromboembolism, making it a hematologic emergency requiring immediate intervention. Pathophysiology of HIT-Associated Thrombosis Thrombosis in

Thromboembolic Disorder

Thromboembolic disorders are conditions characterized by the abnormal formation and migration of blood clots within the circulatory system. These clots, or thrombi, may form in veins or arteries and can travel through the bloodstream, causing embolic events that obstruct blood flow to vital organs. This disruption can lead to severe clinical outcomes, including pulmonary embolism,

Thrombocytosis in Myeloproliferative Disease

Thrombocytosis is defined as a sustained elevation in platelet count exceeding 450,000/μL. When occurring in the context of myeloproliferative neoplasms (MPNs), this hematologic abnormality is typically a result of clonal proliferation of megakaryocytes in the bone marrow. Unlike reactive thrombocytosis, which is a response to inflammation or tissue damage, MPN-related thrombocytosis reflects an intrinsic defect

Thick Bronchial Secretions

Thick bronchial secretions refer to abnormally viscous mucus accumulating within the bronchial tubes. These secretions are typically composed of water, glycoproteins, lipids, and immune cells. Under normal conditions, mucus traps inhaled particles and pathogens, and cilia on the bronchial lining help expel it. However, when mucus becomes thick and sticky, it hinders clearance, leading to

Thiamine Deficiency

Thiamine, also known as vitamin B1, is a water-soluble vitamin essential for energy metabolism, nerve function, and glucose utilization. It serves as a coenzyme in key biochemical processes, including the Krebs cycle and the pentose phosphate pathway. As the human body cannot synthesize thiamine, it must be obtained from the diet. Deficiency can lead to

Tetanus-Diphtheria Prevention

Tetanus and diphtheria are life-threatening bacterial infections that, while rare in industrialized nations, continue to pose significant health risks globally. Prevention strategies for both diseases rely on the effectiveness of tetanus-diphtheria (Td) and tetanus-diphtheria-pertussis (Tdap) vaccines. These diseases are preventable with timely immunization and booster coverage, making adherence to recommended vaccination schedules critical for individual